Skip to main content

Skye Bioscience, Inc PREM14A, filed Oct 26, 2026

Skye Bioscience, Inc. (SKYE)

Skye Bioscience proposes acquiring Redx Pharma Limited, renaming the combined company Fibrx Therapeutics, Inc., and seeking stockholder approval for related share issuances, financing, charter amendments, compensation and meeting adjournment. AI summary

PREM14A 2026-10-26 For: 2026-10-26
View Original
Added on October 26, 2026